Insight Molecular Diagnostics Stock Analysis

Insight Stock Analysis Notes

About 22.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.79. Insight Molecular had not issued any dividends in recent years. The entity had 1:20 split on the 25th of July 2023. To learn more about Insight Molecular Diagnostics call Joshua Riggs at 949 409 7600 or check out https://imdxinc.com.

Insight Molecular Investment Alerts

Insight Largest EPS Surprises

View All Earnings Estimates

Insight Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 86.66 M.

Insight Profitablity

Management Efficiency

Insight Molecular has return on total asset (ROA) of (0.2217) % which means that it has lost $0.2217 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.2896) %, meaning that it created substantial loss on money invested by shareholders. Insight Molecular's management efficiency ratios could be used to measure how well Insight Molecular manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 4.67 in 2026, despite the fact that Return On Tangible Assets are likely to grow to (3.24). At this time, Insight Molecular's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 32.8 M in 2026, whereas Other Current Assets are likely to drop slightly above 1.1 M in 2026.

Technical Drivers

As of the 8th of February, Insight Molecular retains the Downside Deviation of 4.58, market risk adjusted performance of 0.155, and Risk Adjusted Performance of 0.0715. Insight Molecular technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Insight Molecular Price Movement Analysis

Insight Molecular Insider Trading Activities

Insight Molecular Outstanding Bonds

Insight Molecular Predictive Daily Indicators

Insight Molecular Corporate Filings

Insight Molecular Forecast Models

Insight Molecular's time-series forecasting models are one of many Insight Molecular's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Insight Molecular's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Insight Molecular Bond Ratings

Insight Molecular Diagnostics financial ratings play a critical role in determining how much Insight Molecular have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Insight Molecular's borrowing costs.

Insight Molecular Total Assets Over Time

Insight Molecular Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Insight Molecular uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Insight Molecular Debt Ratio

23.0

It appears most of the Insight Molecular's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Insight Molecular's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Insight Molecular, which in turn will lower the firm's financial flexibility.

Insight Molecular Corporate Bonds Issued

Insight Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Insight Molecular prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Insight shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Insight Molecular. By using and applying Insight Stock analysis, traders can create a robust methodology for identifying Insight entry and exit points for their positions.

When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.